Foundation for Biomedical Research and Innovation, Kobe, Japan.
Exp Hematol. 2010 Feb;38(2):154-62. doi: 10.1016/j.exphem.2009.11.003. Epub 2009 Nov 14.
Cord blood banks provide fully human leukocyte antigen-typed cells, from which a set of standard induced pluripotent stem (iPS) cells for use in allogenic transplantation can be derived. Hence, the ability to generate iPS cells from cord blood cells has the potential to provide a suitable source for clinical transplantation. The aim of this work is to determine the reprogramming methods, culture conditions, and cell fractions that can be used to generate iPS cells from cord blood cells effectively.
CD34(+), mononucleated, and derived adherent cells from cord blood were cultured in hematopoietic medium (X-vivo10 containing 50 ng/mL interleukin-6, 50 ng/mL soluble interleukin-6 receptor, 50 ng/mL stem cell factor, 10 ng/mL thrombopoietin, and 20 ng/mL Flit3/4 ligand) 3 days prior to viral infection. Cells were then infected with retroviral constructs driving the expression of OCT3/4, SOX2, Krüppel-like factor 4, c-MYC, and enhanced green fluorescent protein together with or without the p53 knockdown lentiviral construct Shp53 pLKO.1-puro. Infected cells were then cultured for an additional 4 days in hematopoietic culture medium before being transferred onto mouse embryonic fibroblast (MEF) or SNL76/7 feeder cells in human embryonic stem cell medium (Dulbecco's modified Eagle medium/F-12 containing 20% knockout serum replacement, 200 mM L-glutamine, 1% non-essential amino acids (NEAA), 0.1 mM 2-mercaptoethanol, and 4 ng/mL basic fibroblast growth factor). Subsequently, the number of embryonic stem cell-like colonies that emerged in the following 4 weeks was scored. Expression of a number of pluripotency makers were examined by immunochemistry and reverse transcriptase polymerase chain reaction. Finally, the differentiation potential of selected colonies was determined by teratoma formation in severe combined immunodeficient mice and in vitro culture.
Repression of p53 expression by the addition of a lentiviral p53 short-hairpin RNA expression vector increased the frequency of formation of iPS-like colonies from 1 (on average) to around 100 per 2 x 10(4) cells when infected cells were grown on SNL feeder cells.
iPS cells can be generated easily from CD34(+) cord blood cells through the addition of p53 inhibition to standard reprogramming conditions.
脐带血库提供完全人白细胞抗原配型的细胞,从中可以衍生出一套用于同种异体移植的标准诱导多能干细胞(iPS)。因此,从脐带血细胞中生成 iPS 细胞的能力有可能为临床移植提供合适的来源。本工作旨在确定有效的从脐带血细胞中生成 iPS 细胞的重编程方法、培养条件和细胞亚群。
将脐带血中的 CD34+、有核、贴壁细胞在造血培养基(含 50ng/ml 白细胞介素 6、50ng/ml 可溶性白细胞介素 6 受体、50ng/ml 干细胞因子、10ng/ml 血小板生成素和 20ng/ml Flit3/4 配体的 X-vivo10)中培养 3 天,然后进行病毒感染。细胞用逆转录病毒载体驱动 OCT3/4、SOX2、Krüppel 样因子 4、c-MYC 和增强型绿色荧光蛋白的表达进行感染,同时或不使用 p53 敲低慢病毒载体 Shp53 pLKO.1-puro 进行感染。感染后的细胞在造血培养基中再培养 4 天,然后转移到 MEF 或 SNL76/7 饲养细胞上,在人胚胎干细胞培养基(含 20%无外源性血清替代物、200mM L-谷氨酰胺、1%非必需氨基酸(NEAA)、0.1mM 巯基乙醇和 4ng/ml 碱性成纤维细胞生长因子的 Dulbecco 改良 Eagle 培养基/F-12)中。随后,在接下来的 4 周内计算出现类胚胎干细胞集落的数量。通过免疫化学和逆转录聚合酶链反应检测多种多能性标志物的表达。最后,通过在严重联合免疫缺陷小鼠中形成畸胎瘤和体外培养来确定选定集落的分化潜力。
通过添加慢病毒 p53 短发夹 RNA 表达载体抑制 p53 的表达,将感染细胞在 SNL 饲养细胞上培养时,从每 2×104 个细胞形成 1 个(平均)左右的 iPS 样集落的频率提高到约 100 个。
通过在标准重编程条件中添加 p53 抑制,可轻松从 CD34+脐带血细胞中生成 iPS 细胞。